Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Early Phase 1
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Early Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04155476Early Phase 1Unknown

Ultrasound Evaluation of Lower Extremity Arteries After Topical Nitroglycerin Administration

Role: lead

NCT02803775Not ApplicableCompleted

Paced And Sensed Electrical Delay in CRT Therapy (PASED CRT)

Role: lead

NCT03412942Not ApplicableUnknown

EndovascuLar RegIstry Evaluating SafeTy, Efficacy and Patient Comfort (ELITE)

Role: collaborator

NCT02510547Phase 4Completed

Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial

Role: collaborator

All 4 trials loaded